Click for best price
Viral Conjunctivitis Drugs Market Size, Share 2023
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.
This report aims to provide a comprehensive presentation of the global market for Viral Conjunctivitis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Conjunctivitis Drugs. This report contains market size and forecasts of Viral Conjunctivitis Drugs in global, including the following market information:
Global Viral Conjunctivitis Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Viral Conjunctivitis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.
We surveyed the Viral Conjunctivitis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Conjunctivitis Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, by Type, 2022 (%)
FST-100
APD-209
Global Viral Conjunctivitis Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
ASCs
Others
Global Viral Conjunctivitis Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Viral Conjunctivitis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Conjunctivitis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Viral Conjunctivitis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adenovir Pharma
Allergan
NanoViricides
Takeda
NovaBay Pharmaceuticals
Novartis
Panoptes Pharma
NicOx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Conjunctivitis Drugs, market overview.
Chapter 2: Global Viral Conjunctivitis Drugs market size in revenue.
Chapter 3: Detailed analysis of Viral Conjunctivitis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Conjunctivitis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Conjunctivitis Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Conjunctivitis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Conjunctivitis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Conjunctivitis Drugs Overall Market Size
2.1 Global Viral Conjunctivitis Drugs Market Size: 2022 VS 2030
2.2 Global Viral Conjunctivitis Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Conjunctivitis Drugs Players in Global Market
3.2 Top Global Viral Conjunctivitis Drugs Companies Ranked by Revenue
3.3 Global Viral Conjunctivitis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Viral Conjunctivitis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral Conjunctivitis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Conjunctivitis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Viral Conjunctivitis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Conjunctivitis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Conjunctivitis Drugs Market Size Markets, 2022 & 2030
4.1.2 FST-100
4.1.3 APD-209
4.2 By Type - Global Viral Conjunctivitis Drugs Revenue & Forecasts
4.2.1 By Type - Global Viral Conjunctivitis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Viral Conjunctivitis Drugs Revenue, 2024-2030
4.2.3 By Type - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Conjunctivitis Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 ASCs
5.1.4 Others
5.2 By Application - Global Viral Conjunctivitis Drugs Revenue & Forecasts
5.2.1 By Application - Global Viral Conjunctivitis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Viral Conjunctivitis Drugs Revenue, 2024-2030
5.2.3 By Application - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Viral Conjunctivitis Drugs Market Size, 2022 & 2030
6.2 By Region - Global Viral Conjunctivitis Drugs Revenue & Forecasts
6.2.1 By Region - Global Viral Conjunctivitis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Viral Conjunctivitis Drugs Revenue, 2024-2030
6.2.3 By Region - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Viral Conjunctivitis Drugs Revenue, 2018-2030
6.3.2 US Viral Conjunctivitis Drugs Market Size, 2018-2030
6.3.3 Canada Viral Conjunctivitis Drugs Market Size, 2018-2030
6.3.4 Mexico Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Viral Conjunctivitis Drugs Revenue, 2018-2030
6.4.2 Germany Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.3 France Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.4 U.K. Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.5 Italy Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.6 Russia Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Viral Conjunctivitis Drugs Market Size, 2018-2030
6.4.8 Benelux Viral Conjunctivitis Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Viral Conjunctivitis Drugs Revenue, 2018-2030
6.5.2 China Viral Conjunctivitis Drugs Market Size, 2018-2030
6.5.3 Japan Viral Conjunctivitis Drugs Market Size, 2018-2030
6.5.4 South Korea Viral Conjunctivitis Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Viral Conjunctivitis Drugs Market Size, 2018-2030
6.5.6 India Viral Conjunctivitis Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Viral Conjunctivitis Drugs Revenue, 2018-2030
6.6.2 Brazil Viral Conjunctivitis Drugs Market Size, 2018-2030
6.6.3 Argentina Viral Conjunctivitis Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, 2018-2030
6.7.2 Turkey Viral Conjunctivitis Drugs Market Size, 2018-2030
6.7.3 Israel Viral Conjunctivitis Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Viral Conjunctivitis Drugs Market Size, 2018-2030
6.7.5 UAE Viral Conjunctivitis Drugs Market Size, 2018-2030
7 Viral Conjunctivitis Drugs Companies Profiles
7.1 Adenovir Pharma
7.1.1 Adenovir Pharma Company Summary
7.1.2 Adenovir Pharma Business Overview
7.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Major Product Offerings
7.1.4 Adenovir Pharma Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.1.5 Adenovir Pharma Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Viral Conjunctivitis Drugs Major Product Offerings
7.2.4 Allergan Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 NanoViricides
7.3.1 NanoViricides Company Summary
7.3.2 NanoViricides Business Overview
7.3.3 NanoViricides Viral Conjunctivitis Drugs Major Product Offerings
7.3.4 NanoViricides Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.3.5 NanoViricides Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Viral Conjunctivitis Drugs Major Product Offerings
7.4.4 Takeda Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 NovaBay Pharmaceuticals
7.5.1 NovaBay Pharmaceuticals Company Summary
7.5.2 NovaBay Pharmaceuticals Business Overview
7.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Major Product Offerings
7.5.4 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.5.5 NovaBay Pharmaceuticals Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Viral Conjunctivitis Drugs Major Product Offerings
7.6.4 Novartis Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Panoptes Pharma
7.7.1 Panoptes Pharma Company Summary
7.7.2 Panoptes Pharma Business Overview
7.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Major Product Offerings
7.7.4 Panoptes Pharma Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.7.5 Panoptes Pharma Key News & Latest Developments
7.8 NicOx
7.8.1 NicOx Company Summary
7.8.2 NicOx Business Overview
7.8.3 NicOx Viral Conjunctivitis Drugs Major Product Offerings
7.8.4 NicOx Viral Conjunctivitis Drugs Revenue in Global Market (2018-2023)
7.8.5 NicOx Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral Conjunctivitis Drugs Market Opportunities & Trends in Global Market
Table 2. Viral Conjunctivitis Drugs Market Drivers in Global Market
Table 3. Viral Conjunctivitis Drugs Market Restraints in Global Market
Table 4. Key Players of Viral Conjunctivitis Drugs in Global Market
Table 5. Top Viral Conjunctivitis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Viral Conjunctivitis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Viral Conjunctivitis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Viral Conjunctivitis Drugs Product Type
Table 9. List of Global Tier 1 Viral Conjunctivitis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Conjunctivitis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Viral Conjunctivitis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Viral Conjunctivitis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Viral Conjunctivitis Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Adenovir Pharma Company Summary
Table 31. Adenovir Pharma Viral Conjunctivitis Drugs Product Offerings
Table 32. Adenovir Pharma Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Adenovir Pharma Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Viral Conjunctivitis Drugs Product Offerings
Table 36. Allergan Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. NanoViricides Company Summary
Table 39. NanoViricides Viral Conjunctivitis Drugs Product Offerings
Table 40. NanoViricides Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. NanoViricides Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Viral Conjunctivitis Drugs Product Offerings
Table 44. Takeda Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. NovaBay Pharmaceuticals Company Summary
Table 47. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Product Offerings
Table 48. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. NovaBay Pharmaceuticals Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Viral Conjunctivitis Drugs Product Offerings
Table 52. Novartis Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Panoptes Pharma Company Summary
Table 55. Panoptes Pharma Viral Conjunctivitis Drugs Product Offerings
Table 56. Panoptes Pharma Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Panoptes Pharma Key News & Latest Developments
Table 58. NicOx Company Summary
Table 59. NicOx Viral Conjunctivitis Drugs Product Offerings
Table 60. NicOx Viral Conjunctivitis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. NicOx Key News & Latest Developments
List of Figures
Figure 1. Viral Conjunctivitis Drugs Segment by Type in 2022
Figure 2. Viral Conjunctivitis Drugs Segment by Application in 2022
Figure 3. Global Viral Conjunctivitis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral Conjunctivitis Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Viral Conjunctivitis Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Conjunctivitis Drugs Revenue in 2022
Figure 8. By Type - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 16. US Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 28. China Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Viral Conjunctivitis Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Viral Conjunctivitis Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Adenovir Pharma Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. NanoViricides Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Panoptes Pharma Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. NicOx Viral Conjunctivitis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
